Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
MedCity News
APRIL 27, 2023
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
Let's personalize your content